Amphetamines are typically detectable in blood for about one to two days after a dose, though the exact window depends heavily on individual factors and which specific amphetamine compound is involved. The plasma half-life of d-amphetamine generally falls in the range of 10 to 13 hours, meaning it takes that long for blood concentrations to drop by half. But that number can shift dramatically based on something as seemingly mundane as how acidic your urine is, and the story gets more interesting from there.
What the Half-Life Actually Means for Detection
A drug’s half-life is the time it takes for the concentration in your blood to fall to half of its peak value. For d-amphetamine, the form found in common ADHD medications like Adderall and Vyvanse, that half-life sits around 10 to 13 hours in most adults. After roughly four to five half-lives, concentrations drop low enough that standard blood tests can no longer pick them up. That math puts the typical detection window somewhere in the neighborhood of 46 to 65 hours for a single therapeutic dose, though in practice many people clear the drug faster than the outer end of that range.
Methamphetamine follows a somewhat different timeline. It has its own half-life of roughly 10 to 12 hours but is also partially converted into amphetamine in the body. That means a person who uses methamphetamine will have both methamphetamine and amphetamine circulating in their blood. In a large forensic dataset of over 8,000 cases where both compounds were present, the mean blood concentration of amphetamine was actually higher than that of methamphetamine itself, reflecting this metabolic conversion.1PubMed. Concentration ratios of methamphetamine to amphetamine in blood can help to distinguish use of methamphetamine from various mixtures of the two stimulants The practical upshot is that methamphetamine use can produce a positive blood test for amphetamine long after the parent drug itself has begun to fall.
The Urine pH Effect
If there is one factor that can swing the detection window more than any other, it is urinary pH. Amphetamines are weak bases, and when your urine is acidic, more of the drug gets trapped in its ionized form inside the kidney tubules and flushed out. When urine is alkaline, the drug stays un-ionized, gets reabsorbed back into the bloodstream, and hangs around much longer. This is not a small effect. Under acidic urine conditions, the half-life of amphetamine can drop to roughly 7 to 8 hours. Under alkaline conditions, it can stretch beyond 20 hours. That is nearly a threefold difference from the same dose of the same drug in the same person, driven entirely by urine chemistry.
Research on this effect dates back decades. A classic study administering racemic amphetamine to healthy volunteers under controlled acidification and alkalinization confirmed that urinary pH dramatically changes how fast amphetamine leaves the body. The study also found that the two mirror-image forms of amphetamine, the (+) and (-) isomers, are not eliminated at the same rate. The (+) form, which is pharmacologically more potent, clears faster than the (-) form, and this difference is most pronounced when urine is alkaline.2PubMed. Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH Mechanistic modeling has confirmed that changes in urine pH can significantly alter renal clearance and overall systemic exposure for both amphetamine and methamphetamine.3PubMed Central. Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine
What controls your urinary pH day to day? Mostly diet and hydration, though certain medications and medical conditions also play a role. High-protein diets and cranberry juice tend to acidify urine. Diets heavy in fruits and vegetables tend to make it more alkaline. Antacids like sodium bicarbonate push urine pH upward. This means that two people taking the same dose of Adderall on the same schedule could have meaningfully different blood levels at the 24-hour mark simply because one had steak for dinner and the other had a salad.
Lisdexamfetamine Is a Special Case
Lisdexamfetamine, sold as Vyvanse, is not amphetamine itself but a prodrug. It is a molecule of d-amphetamine chemically bonded to the amino acid lysine. This bond has to be broken before the active drug is released, and that cleavage happens in an unusual place: inside red blood cells. In vitro experiments show that lisdexamfetamine is completely stable in plasma alone for at least four hours, with no detectable d-amphetamine appearing. But in whole blood, where red blood cells are present, the prodrug is steadily converted, with a half-life of about 1.6 hours for the conversion process. After four hours in whole blood, roughly 82% of the intact prodrug had been converted to d-amphetamine.4PubMed Central. Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
The absorption of intact lisdexamfetamine from the gut appears to involve a high-capacity transporter system, and its conversion in the blood is similarly high-capacity. This helps explain why Vyvanse produces more consistent, reproducible blood levels of d-amphetamine compared to taking d-amphetamine directly.5PubMed Central. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine A clinical trial comparing the two formulations head-to-head found that the stimulant effects of lisdexamfetamine occurred later than those of d-amphetamine, consistent with the time needed for the prodrug conversion. However, the peak effects themselves, including heart rate changes, blood pressure increases, and subjective feelings, were ultimately comparable.6PubMed Central. Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
For the question of how long amphetamine stays in your blood, the lisdexamfetamine distinction matters in a practical way. The delayed release means peak blood concentrations arrive later, which can push the tail end of detection slightly later as well compared to an equivalent immediate-release dose. Once the d-amphetamine is freed from its lysine carrier, though, it follows the same elimination kinetics as any other d-amphetamine.
Liver Enzymes and Genetic Variation
Your liver processes amphetamines using a family of enzymes called cytochrome P450, and the specific enzyme CYP2D6 has gotten the most research attention. In laboratory studies, essentially all amphetamine-type compounds interact with CYP2D6 as either substrates (meaning the enzyme breaks them down) or competitive inhibitors (meaning they block the enzyme from working on other drugs).7PubMed. Interactions of amphetamine analogs with human liver CYP2D6 The CYP2D6 gene is famously variable across the population. Some people carry gene variants that make them “poor metabolizers” (they break drugs down slowly), while others are “ultra-rapid metabolizers” (they chew through certain drugs unusually fast).
Here is where the evidence gets a bit surprising. Despite the strong in vitro data showing CYP2D6’s involvement, in vivo studies suggest the enzyme’s actual contribution to amphetamine clearance is lower than lab results would predict. Other P450 enzymes and, crucially, direct renal excretion of unchanged drug play substantial roles in clearing amphetamines from the body.8PubMed Central. MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant? A forensic study examining CYP2D6 genetic variants in autopsy cases found no association between CYP2D6 metabolizer status and amphetamine concentrations in body fluids.9PubMed. Association between cytochrome P450 2D6 polymorphisms and body fluid methamphetamine concentrations in Japanese forensic autopsy cases In other words, knowing someone’s CYP2D6 genotype does not reliably predict how fast they will clear amphetamine from their blood. The kidney’s role in directly excreting the unchanged drug, which is where urine pH has its outsized influence, may matter more than liver metabolism for this particular drug class.
Blood Levels Do Not Perfectly Track How You Feel
One of the more counterintuitive findings about amphetamines is that the time course of blood levels does not neatly line up with the time course of the drug’s effects. A study in healthy volunteers found that subjective psychological effects, cognitive changes, and blood pressure responses frequently did not mirror the rise and fall of plasma amphetamine concentrations.10PubMed. Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers You might feel the drug wearing off while blood levels are still near their peak, or experience residual effects after concentrations have dropped substantially.
People also differ in when they experience peak subjective effects. Research has identified “early peak responders” and “late peak responders” who differ in how quickly their plasma d-amphetamine levels rise and how their heart rate responds. Early peak responders showed faster-rising blood levels and a more sustained increase in heart rate compared to late peak responders.11PubMed Central. Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology This means that even when two people have similar total exposure over time, their subjective experience of how long the drug “lasts” can differ considerably. If you are trying to gauge whether amphetamine is still in your blood based on how you feel, you are likely to be wrong in both directions.
How Blood Compares to Other Testing Matrices
Blood is not the most common specimen collected for amphetamine drug testing. Urine is far more popular in workplace and clinical settings because it is less invasive to collect and generally has a longer detection window, typically two to four days for amphetamines. But blood testing is preferred in specific contexts, particularly forensic toxicology, impaired-driving investigations, and clinical situations where knowing the current concentration matters more than knowing whether someone used the drug last week.
Oral fluid (saliva) testing has become increasingly common, especially in roadside testing programs. Concentrations of basic drugs like amphetamines in oral fluid tend to be similar to or even higher than those in plasma.12PubMed Central. Drug testing in oral fluid This makes saliva a practical alternative when blood draws are impractical. Research aimed at establishing equivalent cutoff concentrations between blood and oral fluid has shown that the correspondence is close enough for regulatory use, with forensic studies testing cutoffs of 200 to 1,000 ng/mL of amphetamine in blood against their saliva equivalents and finding accuracy within about 20%.13PubMed. Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: a study of tetrahydrocannabinol and amphetamine
Hair testing occupies the other end of the time spectrum, capable of detecting amphetamine use months after the last dose. An interesting wrinkle in hair testing is that external contamination from blood is a real concern. Experiments have shown that hair exposed to blood containing amphetamines can become contaminated within as little as six hours, and the contamination worsens with higher drug concentrations in the blood and longer contact times.14Forensic Science International. Evaluation of amphetamines diffusion in hair after contact with amphetamines-containing blood This matters for forensic casework where a victim’s hair might come into contact with a suspect’s blood at a scene.
Children and Adults Do Not Clear Amphetamines at the Same Rate
Most of the pharmacokinetic data commonly cited for amphetamines comes from studies in adults. But amphetamines are prescribed overwhelmingly for ADHD, and a large share of those prescriptions go to children and adolescents. The pharmacokinetics of amphetamines differ between children and adults, with children generally clearing the drug faster.15PubMed Central. Potential adverse effects of amphetamine treatment on brain and behavior: a review This means a child taking a therapeutic dose may have a shorter detection window in blood than an adult taking the same weight-adjusted dose. It also has implications for dosing: faster clearance can mean the therapeutic effect wears off sooner, which is one reason pediatric dosing schedules sometimes differ from adult ones.
Older adults may also handle the drug differently, though this has been studied less. Age-related declines in kidney function reduce the ability to excrete unchanged amphetamine, potentially extending the detection window. The clinical significance of this depends on the individual’s renal health, but it is one reason that prescribers sometimes start older patients on lower doses.
False Positives on Amphetamine Screens
If you are concerned about an amphetamine blood test because you take a different medication that might trigger a positive result, you have legitimate reason to pay attention. Immunoassay-based drug screens, which are the most common initial screening method, work by detecting structural similarity to amphetamine. The problem is that plenty of other molecules look enough like amphetamine at the molecular level to fool the test.
The list of medications known to cause false-positive amphetamine screens is long and sometimes surprising. It includes common antihistamines, several antidepressants (including fluoxetine and trazodone), the Parkinson’s drug selegiline, the blood pressure medication labetalol, the diabetes drug metformin, and over-the-counter decongestants containing pseudoephedrine or ephedrine.16PubMed Central. Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine17Current Analytical Chemistry. Common Causes of False Positive and False Negative Results in Amphetamine Screening Tests Even the anti-seizure medication fenfluramine, prescribed for Dravet syndrome in children, can trigger a false positive at its recommended dose.18PubMed Central. Fenfluramine: An Uncommon Cause of False Positive Urine Drug Testing: A Case Report
The key point is that an initial immunoassay screen is only a preliminary result. A confirmatory test using mass spectrometry can distinguish true amphetamine from structurally similar imposters with high accuracy. If you are taking any of the medications above and face a drug test, disclosing your prescriptions before the test and requesting confirmatory testing if the screen comes back positive is the sensible approach.
The Vitamin C Myth
A persistent piece of internet pharmacology lore holds that taking large doses of vitamin C (ascorbic acid) will flush amphetamines from your system faster by acidifying urine. The logic is not entirely wrong in principle: ascorbic acid can lower urine pH, and as discussed earlier, acidic urine does speed amphetamine excretion. But the practical reality is less tidy. A study in rats given a very large dose of ascorbic acid found no effect on amphetamine’s half-life in the brain and no change in amphetamine-driven behavior.19PubMed Central. Effect of ascorbic acid on brain amphetamine concentrations in the rat While this was an animal study focused on brain concentrations rather than blood levels, it suggests the effect of casual vitamin C supplementation is far less dramatic than online forums claim. The doses needed to meaningfully shift urine pH are large, the effect on systemic clearance is modest compared to the kidney-specific effect, and the degree of pH change achievable through diet or supplements is much smaller than what researchers create in controlled laboratory settings.
What Extended-Release Formulations Mean for the Timeline
Most amphetamine prescriptions today use some form of extended-release technology rather than immediate-release tablets. These formulations are designed to release the drug gradually over 8 to 16 hours, depending on the specific product. From the perspective of blood detection, this matters because the drug is still being absorbed while earlier portions of the dose are being eliminated. The net result is a flatter blood-level curve over a longer period, which can extend the tail end of detectability somewhat compared to an equivalent total dose taken as a single immediate-release tablet.
For someone taking a once-daily extended-release amphetamine at a steady therapeutic dose, the drug reaches a predictable steady-state concentration in the blood. At steady state, each new dose tops off what remains from yesterday’s dose, meaning blood levels never fully reach zero between doses. If you stop taking the medication, it takes several days for blood levels to drop below detection limits, because you are clearing the accumulated steady-state concentration rather than just a single dose. Roughly speaking, expect four to five half-lives from the last dose, which translates to about two to three days for most people taking d-amphetamine formulations.
MDMA and Other Amphetamine Analogs
The amphetamine family extends well beyond prescription medications. MDMA (ecstasy), MDA, and methamphetamine are all amphetamine-type stimulants, and standard drug screens often detect several of these under the umbrella “amphetamines” category. Each has somewhat different pharmacokinetics. MDMA and MDA are metabolized primarily through a demethylenation step, with CYP2D6 playing a more prominent role in their breakdown compared to plain amphetamine.20PubMed. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers This means that for MDMA, unlike for standard amphetamine, a person’s CYP2D6 genetic status may actually affect how long the drug lingers in their blood.
MDMA is also itself converted in part to MDA in the body, so a blood test after MDMA use will often show both compounds. The detection window for MDMA in blood is generally shorter than for d-amphetamine, typically under 24 hours for a single recreational dose. Methamphetamine, as noted earlier, produces amphetamine as a metabolite, so blood testing after methamphetamine use creates a more complex picture with two detectable compounds on overlapping timelines.